Stoquity Living researchResearch LedgerSlicesMethodologyFor institutionsAbout
Stoquity Research Ledger

PTC Therapeutics Inc. (PTCT)

NASDAQ: PTCT · Pharmaceutical Preparations · Warren, NJ

Our rating: Positive

Positive reaffirmed at $59.97, high conviction, October 30, 2026.

Breaks if: The Positive call is wrong if annual revenue in the next reported fiscal year falls more than 15% below the current $1.7B — that is, lands below roughly $1.45B — or if free cash flow margin drops below 25% for two consecutive quarters (it currently sits above 40%). Either outcome would indicate the commercial surge is unwinding faster than the already-depressed multiple assumes, and the valuation cushion would narrow sharply. Conversely, the call would strengthen toward Conviction if a subsequent filing or disclosure reveals durable late-stage pipeline assets with near-term catalysts that could sustain or extend the current revenue base.

Key figures

Market value$4.7B
Revenue, last 12 months$1.2B
Net income, last 12 months−$106M
Free cash flow, last 12 months$2M
Price to earningsn/a
Free cash flow yield0.0%
Dividend yield0.0%
Operating margin12.8%
Return on equityn/a
Beta to the S&P 5000.98
Volatility, annualized49.5%

Reported quarters

Quarter endingRevenueYear on yearEarnings per shareFree cash flow
September 30, 2026$358M69.6%$-0.62−$28M
June 30, 2026$361M101.5%$0.92$127M
March 31, 2026$273M−76.8%$-0.03−$60M
December 31, 2025$165M−22.7%$-1.67−$37M
September 30, 2025$211M7.2%$0.20−$70M
June 30, 2025$179M−4.2%$-0.83−$60M
March 31, 2025$1.2B459.7%$10.04$868M
December 31, 2024$213M−30.6%$-0.85−$34M

Three-model forecasts for the next quarter

Written November 21, 2026, before the report. Each settles from the SEC filing.

10 ledger entries and 45 corporate events on record. Share price as of November 20, 2026. Research and education only. Not investment advice. Stoquity does not manage money or know your circumstances. Ratings, forecasts and lists are produced by software and AI models and can be wrong. Performance figures are hypothetical, measured on paper against a benchmark, and say nothing certain about the future.